España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Mineralys Therapeutics
MLYS
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.89
-0.69
-4.73%
At Close: -
$13.89
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Mineralys Therapeutics (MLYS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Mineralys Therapeutics (NASDAQ:MLYS) Stock
Mineralys Therapeutics Stock (NASDAQ: MLYS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 10, 2024
HC Wainwright & Co. Initiates Coverage On Min...
Benzinga Newsdesk
Thursday, May 09, 2024
Mineralys Therapeutics Q1 2024 GAAP EPS $(0.7...
Benzinga Newsdesk
Tuesday, April 02, 2024
Mineralys Therapeutics shares are trading hig...
Benzinga Newsdesk
Goldman Sachs Initiates Coverage On Mineralys...
Benzinga Newsdesk
Thursday, March 21, 2024
Mineralys Therapeutics Q4 EPS $(0.61) Beats $...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights
Wednesday, March 20, 2024
Mineralys Therapeutics Earnings Preview
Benzinga Insights
Thursday, February 08, 2024
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Mineralys Therapeutics shares are trading hig...
Benzinga Newsdesk
Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Mineralys Therapeutics Announces $120M Privat...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Thursday, December 21, 2023
Mineralys Reports First Subject Dosed In Laun...
Benzinga Newsdesk
Saturday, November 11, 2023
Mineralys Therapeutics Further Defines Endoty...
Benzinga Newsdesk
Tuesday, November 07, 2023
Mineralys Therapeutics Q3 EPS $(0.57) Beats $...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Thursday, November 02, 2023
Mineralys Therapeutics Presents New Post-Hoc ...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 11, 2023
$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying
Lisa Levin
Sunday, September 10, 2023
Mineralys Therapeutics Announced Target-htn Successfully Met Its Primary Endpoint; Key Secondary Endpoint Results Demonstrated A Change In Diastolic Aobp Of -7.1 Mmhg With 50mg
Charles Gross
Mineralys Therapeutics Announced JAMA Publication Of Full Target-HTN Phase 2 Trial Results for Lorundrostat In Uncontrolled and Treatment-Resistant Hypertension
Charles Gross
Wednesday, September 06, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, September 05, 2023
Mineralys Therapeutics Selected For Oral Poster Presentation Of Target-HTN Phase 2 Trial Results At 2023 AHA Hypertension Scientific Sessions
Happy Mohamed
Tuesday, August 08, 2023
Credit Suisse Maintains Outperform on Mineral...
Benzinga Newsdesk
Monday, August 07, 2023
Mineralys Therapeutics Q2 EPS $(0.31) Beats $...
Benzinga Newsdesk
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Earnings Scheduled For August 7, 2023
Benzinga Insights
Monday, July 17, 2023
Mineralys Therapeutics Announces Expansion Of...
Benzinga Newsdesk
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
David Willey
-
Sponsored
Tuesday, May 16, 2023
Where Mineralys Therapeutics Stands With Analysts
Benzinga Insights
Credit Suisse Reiterates Outperform on Minera...
Benzinga Newsdesk
Monday, May 15, 2023
Mineralys Therapeutics Q1 EPS $(0.51) Beats $...
Benzinga Newsdesk
Earnings Scheduled For May 15, 2023
Benzinga Insights
Tuesday, May 02, 2023
Mineralys Therapeutics Has Dosed The First Pa...
Benzinga Newsdesk
Friday, April 28, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, April 10, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, March 21, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, March 16, 2023
Where Mineralys Therapeutics Stands With Analysts
Benzinga Insights
Credit Suisse Maintains Outperform on Mineral...
Benzinga Newsdesk
Wednesday, March 15, 2023
Mineralys Therapeutics Q4 EPS $(1.74) Misses ...
Benzinga Newsdesk
Earnings Scheduled For March 15, 2023
Benzinga Insights
Friday, March 10, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, March 07, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Benzinga Insights
Evercore ISI Group Initiates Coverage On Mine...
Benzinga Newsdesk
Wells Fargo Initiates Coverage On Mineralys T...
Benzinga Newsdesk
Credit Suisse Initiates Coverage On Mineralys...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Mineralys Th...
Benzinga Newsdesk
B of A Securities Initiates Coverage On Miner...
Benzinga Newsdesk
Stifel Initiates Coverage On Mineralys Therap...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch